rationalize how these enzyme subfamilies recognize unique sets of crRNAs that enable orthogonal RNA detection in complex mixtures. Together, these findings provide new insights into the mechanisms controlling crRNA generation by, and target-RNA activation of, Cas13a.
RESULTS

Global architecture of the LbaCas13a-crRNA complex
The Cas13a enzyme family depends on two distinct nuclease activities for biological function, yet neither nuclease active site has been well described in terms of mechanism or conformational regulation. 
a r t i c l e s
To further investigate the mechanisms of pre-crRNA processing and activator-driven HEPN nuclease activity, we studied a divergent A-cleaving homolog, LbaCas13a, thereby enabling comparisons to previously investigated U-cleaving subfamily members LshCas13a and Leptotrichia buccalis (Lbu) Cas13a (Fig. 1a) . We determined the crystal structure of LbaCas13a (residues 1-1,437) in complex with a mature crRNA to 2.0-Å resolution using native single-wavelength anomalous dispersion (SAD) (Fig. 1b-d , Table 1 and Supplementary  Fig. 1a ). To obtain a mature crRNA for binary complex crystallization, we incubated LbaCas13a with a 60-nucleotide (nt) pre-crRNA, allowing the enzyme to process the crRNA, before purifying the resulting complex (Supplementary Fig. 1b) . The mature crRNA within the structure was resolved as 41 well-ordered nucleotides that included the 28-nt 5′ direct repeat (henceforth referred to as the 5′ handle) (A(−28)-C(−1)) and 13 nucleotides of the 3′ spacer. Only the first 13 nucleotides (C1-G13) of the 3′ spacer are well ordered within the crystal structure, with the remaining 11 nucleotides G14-C24 present but disordered ( Fig. 1b and Supplementary Fig. 1c ). LbaCas13a adopts a predominantly α-helical fold comprising six discrete domains that encase the crRNA to form an active surveillance complex (Fig. 1c,d) . Consistent with that of other single-protein CRISPR effectors, its overall architecture is bilobed; the N-terminal domain (NTD) and the Helical-1 domain form the crRNA-recognition (REC) lobe, and the HEPN1, Helical-2, Helical-3, and HEPN2 domains form the nuclease (NUC) lobe. The crRNA 5′ handle is bound by the REC lobe within a positively charged channel formed between the NTD and Helical-1 domain, and the spacer is channeled into a cavity formed within the NUC lobe ( Fig. 1d and Supplementary Fig. 1c) . The NUC lobe encompasses two distinct structural domains, NUC1 and NUC2, that 'sandwich' the targeting region of the crRNA into a planar orientation ( Fig. 1d and Supplementary Fig. 1c) . The NUC1 lobe contains the N-terminal half of HEPN1 (HEPN1-I) and the large α-helical domain Helical-2. The NUC2 lobe comprises the C-terminal half of HEPN1 (HEPN1-II) and the Helical-3 and HEPN2 domains. The overall architecture of this A-cleaving Cas13a is related to that of the U-cleaving LshCas13a (ref. 16) , with notable differences in the NTD and Helical-3 domain positions (Supplementary Fig. 2 ).
Recognition of a compact and divergent crRNA handle
A hallmark of CRISPR-interference complexes is highly specific and tight binding between effector proteins and their cognate crRNA [18] [19] [20] [21] [22] . Multiple-sequence alignment of the crRNA repeat across both Cas13a subfamilies suggests that the 5′ handle of Type VI-A CRISPR-Cas systems forms a conserved hairpin structure comprising a 5-nt base-paired stem, an 8-9-nt loop, and a 2-nt bulge within the stem 14 (Fig. 2a) . Previous work established that LbaCas13a can process and utilize crRNA handles from all A-cleaving subfamily members but cannot utilize crRNA handles from the related U-cleaving subfamily despite the similarity of their predicted structures 14 (Fig. 2a) . We wondered whether our structure could inform us on the molecular basis for the restrictions on Cas13a subfamily crRNA exchangeability.
The structure of LbaCas13a revealed that the crRNA preference is determined by a combination of loop conformation and a divergent set of contacts between the 5′ handle and Cas13a (Fig. 2b-f and Supplementary Fig. 3a) . LbaCas13a binds to its cognate crRNA with high affinity (Supplementary Fig. 4a ) through an extensive network of conserved sugar-phosphate and nucleobase interactions within a cavity formed by the NTD and Helical-1 domains (Figs. 1d and 2b and Supplementary Fig. 3a) . The 5′ handle of LbaCas13a's cognate crRNA is highly compact, as the loop (A(−18)-A(−11)) is condensed into a helical stack (Fig. 2b-d) . Only A(−14) is extruded from the cavity and disordered in the solvent (Fig. 2b and Supplementary Fig. 1c ). This conformation is in stark contrast to the structure of U-cleaving LshCas13a's crRNA, in which A(−13), A(−15), U(−17), and A(−18) are flipped out of the loop (Fig. 2b) .
The 5′ handle makes both structure-and sequence-specific contacts with LbaCas13a (Fig. 2c,d,f and Supplementary Fig. 3a) . In LbaCas13a, the loop is stabilized by the arrangement of the purines into a quadruple-and triple-base stack on either side of the single extruded nucleotide A(−14). The quadruple π-stack (A(−11)−A(−13), A(−15)) is extended to include Y376 of Helical-1 and is stabilized by base-specific interactions with R369, E410, and E406 (Fig. 2c) . Notably, the nucleobases involved in these interactions, G(−12) and A(−15), are strictly conserved within the Type VI-A family (Fig. 2a) . The equivalent nucleotides in the Lsh-crRNA (G(−15) and A(−18)) make no base-specific contacts with LshCas13a, consistent with our previous observation that LbaCas13a and LshCas13a cannot functionally exchange crRNA 14 . Parallel to the quadruple-base stack, nucleotides G(−16)-A(−18) stack between the NTD and Helical-1 domain, forming a triple-base stack that is stabilized by R270 forming hydrogen bonds with backbone phosphates and G(−16) (Fig. 2d) . The proximity of the two sets of stacking nucleotides is further stabilized by a hydrogen bond between the ribose 2′ hydroxyl of G(−12) and nucleobase N3 of A(−17), another contact unique to the compact loop of LbaCas13a.
Beyond stabilizing the crRNA loop, Helical-1 also positions the 5′ flank of the stem-loop in a shallow surface-exposed groove at the interface with HEPN2 (Figs. 1d and 2e) . crRNAs from the A-cleaving subfamily maintain a 5-nt 5′ flank, which wraps around the exterior of LbaCa13a, with A(−25) and G(−26) stacking with F1300 and F422, respectively (Fig. 2e) . Upstream of the 3′ flank, Lba crRNA contains a 2-nt bulge neighboring an A-U base pair that is invariant across the direct repeats of the Type VI-A family. In contrast, the identity of the bulged bases varies as a function of subfamily (Fig. 2a) , suggesting that this portion of the sequence may be a crucial feature for crRNA recognition between the two subfamilies. Consistent with this hypothesis, the AA 3′ bulge observed in LbaCas13a (A(−6)-A(−5)) is read sequence specifically ( Fig. 2f and Supplementary Fig. 3a) . A(−6) engages in a conserved pocket formed by HEPN1-II and Helical-2 where it stacks with Y928, ordering the nucleobase N7 and amine to make a hydrogen bond with E921 and Q927, respectively. A(−5) is buried in a pocket formed at the interface of the NTD, Helical-1, and HEPN1-I domains, where it interacts with the backbone carbonyl and side chain hydroxyl of T21 (Fig. 2f) . The set of contacts that recognize A(−6) in LbaCas13a closely resemble those reading out the equivalent A(−8) in LshCas13a (ref. 16 ). In contrast, the second nucleotide of the AC bulge in LshCas13a (C(−7)) engages in a nucleobase-specific pocket, suggesting that the A-cleaving subfamily has diverged to allow for adenosine at this position.
Although the REC lobe confers crRNA 5′-handle specificity in both U-and A-cleaving Cas13a subfamilies, the landscape of protein-RNA interactions is markedly different. Our structure has revealed differences in crRNA conformation that could not be predicted through simple RNA-folding algorithms. The structure-and sequence-specific contacts observed in LbaCas13a serve to rationalize the previous finding that LbaCas13a cannot effectively utilize noncognate crRNA from the U-cleaving subfamily 14 .
Spacer recognition and activation of LbaCas13a
Cas13a-crRNA complexes show no general RNase activity in the absence of a complementary ssRNA activator, thereby suggesting that the enzyme is able to achieve complete conformational inhibition until the activator is bound. The binary LbaCas13a-crRNA structure represents the target search complex, allowing us to understanda r t i c l e s the structural constraints on both target identification and HEPN nuclease activation.
We observed unambiguous density for a contiguous stretch of 13 spacer nucleotides immediately proximal to the repeat (C1-G13) (Fig. 3a) . The remaining 11 spacer nucleotides, though present in the crystal (Supplementary Fig. 1b) , were disordered in the structure (Supplementary Fig. 1c ). The repeat-proximal portion of the spacer adopts a distorted U-turn conformation in a pocket between NUC1 and NUC2 (Fig. 3b) . Several sugarphosphate interactions stabilize the highly distorted RNA conformation within the NUC lobe ( Supplementary Fig. 3a) . Though the discontinuous spacer nucleotides within LshCas13a appear to follow a similar trajectory, our structure provides a more holistic view of spacer orientation within the NUC lobe. The crystal structure of LshCas13a also revealed preordered A-form-spacer nucleotides bound to the NTD 16 , which we did not observe in LbaCas13a.
The conformation of the LbaCas13a spacer led us to wonder whether spacer length would dramatically impact the HEPN nuclease activity of LbaCas13a. Other homologs have demonstrated HEPN nuclease activation with a variety of spacer lengths, ranging from 20 to 28 nt 10,17 . We did not observe a significant effect of spacer length on rates of LbaCas13a trans-ssRNA cleavage across this range ( Supplementary Fig. 4b,c) . We solved an additional structure of LbaCa13a complexed with a crRNA containing a 20-nt spacer ( Table 1 and Supplementary Fig. 1b) . Although the overall protein structure was identical to that of the complex containing the 24-nt spacer, we observed disorder and partial occupancy of the crRNA spacer within the NUC lobe of the complex containing the 20-nt spacer (Supplementary Fig. 1d ). These observations suggest that LbaCas13a accommodates a range of spacer lengths, sequence identities, and conformations within the spacer cavity, consistent with its role as an adaptive RNA-guided immune system.
We examined the entirety of the bound spacer within LbaCa13a to identify interactions between the NUC lobe and the crRNA spacer. The HEPN, Helical-2 and Helical-3 domains make a number of conserved contacts with the sugar-phosphate backbone of the spacer ( Fig. 3c and Supplementary Fig. 3a-c) . Notably, the 3′ end of the ordered of the spacer (C11-G13) emerges from the NUC lobe, where it adopts an A-form conformation as C11 stacks with F1293 and F1338 of HEPN2, effectively gating access to the proximal spacer sequence that is sandwiched within the NUC lobe (Fig. 3c) . The nucleotides emerging from the NUC lobe adopt a similar conformation in LshCas13a and in our second structure of LbaCas13a (containing a 20-nt spacer) ( Fig. 3c and Supplementary Fig. 1d,e) . Additionally, there are two highly conserved pockets that extensively contact the sugar-phosphate backbone around spacer nucleotides A6 and A8, rendering those Fig. 3b,c) . These structural observations suggest that the Cas13a-crRNA complex orders the repeat-proximal portion of the spacer into a distorted U turn while conformationally gating HEPN nuclease activation through an extensive network of interactions with the sugar-phosphate backbone. Further biochemical and structural studies will be required to determine how the spacer rearranges upon activator binding and how this conformational change triggers Cas13a HEPN domain activation. We also sought to understand how crRNA-bound LbaCas13a is competent for target search but not active for trans-ssRNA cleavage. Evidence from both biochemical and structural experiments has suggested that U-cleaving Cas13a enzymes are dependent on the formation of a composite active site comprised of two RX 4 H motifs, one contributed by each HEPN domain 8, 10, 16, 17 . In agreement with the catalytic requirements of the U-cleaving subfamily, double mutation of the conserved arginine and histidine within either HEPN1 (R600 H605) or HEPN2 (R1243 H1248) abolished general RNase activity of LbaCas13a ( Fig. 3d and Supplementary Fig. 4e,f) . In the LbaCas13a structure, the HEPN1 motif adopts a conformation in which α2 of HEPN1-I is distorted, burying H605 of the RX 4 H motif distant from the putative active site beneath a loop of HEPN2 (Fig. 3e) . Given this remote and solvent-inaccessible positioning, we questioned whether H605 participates in HEPN nuclease activity. Similar to double mutations in HEPN1 or HEPN2, the single H605A substitution was sufficient to render LbaCas13a catalytically inactive (Fig. 3d) , thus suggesting that activation of the enzyme requires H605 to join the surface-exposed HEPN motif. Overall, these data demonstrate that the HEPN nuclease remains inactive before ssRNA-activator binding owing to the crRNA-assisted separation of HEPN active-site residues. These data extend the previous mechanistic understanding gained from the LshCas13a structure, from which it was observed that the HEPN domains were surface exposed and formed a composite active site 16 . Activator binding must induce a synergistic conformational change involving the release of the spacer from the NUC lobe cavity and accommodation of the activator-spacer RNA duplex, similar to the target-RNA-binding mechanism observed in human Ago2 and LbuCas13a (refs. 23,24) .
Active site for Cas13a crRNA maturation Pre-crRNA processing is broadly conserved within the Cas13a family, yet despite extensive mutagenesis studies, the precise active-site residues and chemical mechanism are unknown 10, 14, 16 . Our binary LbaCas13a-crRNA structure represents the product-bound state of the pre-crRNA-processing reaction, prompting us to examine the mature crRNA 5′ terminus for insights into the catalytic mechanism. The structure revealed that the 5′ flank (C(−24)-A(−28)) is directed away from the core of the enzyme and into a surface-exposed groove formed by the Helical-1 and HEPN2 domains (Fig. 4a) . Both Helical-1 and HEPN2 extensively interact with the sugar-phosphate backbone of the 5′ flank, thereby stabilizing the crRNA in the product-bound state (Supplementary Fig. 3a) . The residues within 
a r t i c l e s
LbuCas13a whose mutation results in processing defects are predicted by conservation to line this processing groove between Helical-1 and HEPN2 (Supplementary Fig. 5 ). The 5′-terminal nucleotide within the LbaCas13a structure, A(−28), has a well-resolved 5′ hydroxyl that is surrounded by H328, K435, and K1320, amino acids that are strictly conserved within the Cas13a A-cleaving subfamily ( Fig. 4a and Supplementary Figs. 3a and 5) .
To test the involvement of H328, K435, and K1320 in crRNA maturation, we substituted alanine at these positions and assayed each point mutant's capacity for pre-crRNA cleavage. All three single-point mutants were completely inactive for pre-crRNA processing, thus confirming the role of H328, K435, and K1320 in the catalysis of crRNA maturation ( Fig. 4b and Supplementary  Fig. 4d ). Further biochemical testing of additional residues near A(−28) revealed that alanine substitutions at K432, D1268, or K1305 completely ablate activity, whereas mutations of W325 or N1232 modestly impact processing ( Fig. 4b and Supplementary  Fig. 4d ). To confirm that the observed mutant phenotypes are catalytic deficiencies and not substrate-binding defects, we assayed mutant HEPN nuclease activity and binding affinity of a pre-crRNA-mimic substrate. With the exception of D1268A, the processing mutants maintained near-wild-type levels of ssRNA trans-cleavage activity (Supplementary Fig. 4e,f) . Furthermore, all of the catalytically implicated LbaCas13a mutants retained wild-type-level binding affinity for both the pre-crRNA mimic and the mature crRNA (Supplementary Fig. 4g-i) .
These structural and biochemical observations are consistent with the idea of crRNA processing occurring via an acid-base mechanism that proceeds through a metal-cation-independent pathway in which the 2′ hydroxyl nucleophilically attacks the scissile phosphate in the 3′ position. To assess the role of divalent cations in pre-crRNA processing, we performed processing reactions in the presence of increasing concentrations of the metal chelator EDTA and observed minimal impacts on LbaCas13a processing activity ( Fig. 4c and Supplementary Fig. 4j) . To confirm the role of the 2′ hydroxyl of G(−29), we assayed the ability of LbaCas13a to process a pre-crRNA substrate in which the catalytic ribonucleotide is substituted for a 2′ deoxynucleotide (dG(−29)) substrate. LbaCas13a was unable to cleave this pre-crRNA-mimic substrate (Fig. 4c) , providing biochemical evidence for the metal-independent acid-base mechanism of pre-crRNA processing.
To provide support for this model of crRNA processing, we crystallized the crRNA-processing-deficient LbaCas13a H328A with a precrRNA substrate bearing two nucleotides 5′ to the scissile phosphate ( Table 1 and Fig. 4d ) Wild-type LbaCas13a can process this truncated pre-crRNA (Supplementary Fig. 4k ), suggesting that this structure represents the precatalytic, substrate-bound state of crRNA processing. The structure revealed that K435 and K1320 are positioned around the scissile phosphate, whereas W325 and N1232 stabilize a distorted C2′-endo conformation of the G(−29) ribose. Furthermore, modeling of H328 into the mutant structure suggests that it would be positioned to contact the scissile phosphate. Interestingly, we did not observe any of the biochemically implicated residues within hydrogen bond distance of the ribose 2′ hydroxyl. The pre-crRNA-bound structure revealed that the 2′ hydroxyl of G(−29) contacts N1232 and a single water molecule that is coordinated by HEPN2 residues K1305 and K1320. These structural observations led us to hypothesize a r t i c l e s that the G(−29) 2′ hydroxyl is deprotonated by an activated water. Consistent with this hypothesis, K1305 is flanked by two carboxylate moieties (D1268 and E1235) that may enable it to act as a general base to activate the coordinated water.
Together, these data suggest a model for LbaCa13a-mediated crRNA processing in which conserved residues within the precrRNA-processing groove between the Helical-1 and HEPN2 domains form an acid-base catalytic center (Fig. 4e) . LbaCas13a binds to its cognate pre-crRNA, positioning the 5′ flank within the processing groove where W325 and N1232 stabilize the ribose of G(−29) in a distorted C2′-endo conformation. This coordination sets up the ribose 2′ hydroxyl for nucleophilic attack on the scissile phosphate, at which point K1305, an activated water, K1320, K435, and H328 participate in proton transfer to facilitate the formation of a 2′-3′-cyclic phosphate on G(−29), leaving behind a mature crRNA with a ribose 5′ hydroxyl on A(−28).
DISCUSSION
The signature proteins of Type VI-A CRISPR-Cas systems, Cas13as, are a remarkably diverse family of RNA-guided enzymes that degrade ssRNA nonspecifically upon binding a spacer-complementary ssRNA activator. In this work, we present high-resolution structures of the LbaCas13a-crRNA complex, revealing the active site for pre-crRNA processing and suggesting a structural gating mechanism of RNAguided HEPN nuclease activity. We also uncovered the key conformational differences between two divergent Cas13a subfamilies, highlighting the molecular basis for orthogonal crRNA preferences. Finally, this study reveals that Cas13a ssRNA-targeting activity is constrained during target search by both crRNA spacer conformation and HEPN domain arrangement.
Initial studies determined that residues important for pre-crRNA processing by two Cas13a homologs, LbuCas13a (ref. a r t i c l e s and HEPN2 domains. Our study extends this work by establishing, based on structural, biochemical, and phylogenetic data, that the active site for pre-crRNA processing by all A-cleaving Cas13a homologs is in the Helical-1-HEPN2 interface. Protein sequence divergence and differing sites of cleavage within pre-crRNA preclude direct comparison to all of the U-cleaving Cas13a subfamily members 14 . Nonetheless, biochemical evidence suggests that LbuCas13a pre-crRNA processing is also metal ion independent and likely occurs in an active site located between the Helical-1 and HEPN2 domains 10, 14 . These results are consistent with our identification of a conserved RNA-processing groove that likely serves to stabilize the crRNA backbone.
After Cas13a associates with its crRNA, the Cas13a-crRNA complex is competent for target surveillance. The high-resolution structures presented in this paper reveal conserved contacts between the spacer and the two halves of the NUC lobe, suggesting that these regions may function in conformational sensing of ssRNA-activator binding. The repeat-proximal portion of the spacer is highly distorted and sequestered within the core of the enzyme, making it unlikely that this pocket could accommodate a complementary activator RNA without significant conformational rearrangements. This contrasts with other RNA-guided nuclease complexes, including Cas9 and Argonaute, which preorder their guides within an extended and accessible cavity 25, 26 . Because of the anchoring of the crRNA 5′ handle within the REC lobe and the U-turn conformation of the spacer, we expect that the activatorbound enzyme may contain distortions from a canonical double helix, similar to the spacer-target duplex observed in Type III Cmr RNA-targeting systems 27 . We propose that LbaCas13a and the distorted crRNA spacer must undergo a concerted conformational change upon association with the ssRNA activator that drives HEPN domain dimerization, forming a composite active site and activating the enzyme for ssRNA cleavage. Consistent with this model of activation, a similar mechanism of ssRNA-activator association driving Cas13 activation was observed for the U-cleaving LbuCas13a (ref. 24 ).
Cas13a represents a novel paradigm within RNA-guided nucleases in which the ordered region of the target-complementary sequence is sequestered within the enzyme, with disordered regions of the guide RNA exposed to solvent. Other RNA-guided nucleases, including the Argonaute family and Cas9, utilize a seed region within their guides for initial nucleic-acid recognition to direct target binding into a preordered A-or B-form guide 28, 29 . The preorganization of the seed sequence accelerates target search and mismatch discrimination by decreasing the entropic cost of target binding 30 . Cas13a does not follow this model for target search, as the solvent-accessible crRNA regions are disordered and the ordered crRNA regions are incompatible with duplex formation. Owing to the kinked and inaccessible spacer nucleotides, complementary ssRNA-activator binding can only occur once the system overcomes this additional energetic barrier, thus raising the question of what energetic parameter drives ternary complex formation.
The Cas13a enzyme family continues to be developed as a platform for RNA detection and programmable RNA binding 13, 14 . Bioengineering of Cas13a will require a complete understanding of how the enzyme carries out target search and is subsequently activated to become a general RNase. Our high-resolution target surveillance structure provides key details about crRNA recognition, processing, and spacer ordering that will advance the development of LbaCas13a as a valuable tool for RNA detection.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
ONLINE METHODS
LbaCas13a protein production and purification. The expression and purification of LbaCas13a was carried out as described elsewhere 14 with modifications summarized here: His 6 -MBP-TEV-tagged Cas13a was prepared in Escherichia coli Rosetta2 (DE3) grown in TB at 37 °C. At an OD 600 of 0.4-0.5, cultures were cooled on ice for 15 min before induction with 0.5 mM IPTG and expression overnight at 16 °C. Soluble His 6 -MBP-TEV Cas13a was loaded onto a 5-mL HiTrap NiNTA column (GE Healthcare) and eluted over a linear imidazole (0.01-0.3 M) via FPLC (ÄKTA Pure). After overnight dialysis and TEV digestion, the eluted LbaCas13a was further purified by ion exchange (5 mL HiTrap SP, GE Healthcare) and size-exclusion chromatography (S200 16/60, GE Healthcare) with 2 mM TCEP supplemented into the gel filtration buffer.
In vitro transcription and purification of RNA. For biochemical experiments, RNA was transcribed and radiolabeled as described previously 14 . For crystallization, pre-crRNA was transcribed in vitro from a PCR-amplified double-stranded DNA template encoding a hepatitis delta virus (HDV) ribozyme 3′ to the precrRNA sequence. Transcriptions were carried out as described previously 10 with the following modifications: pre-crRNAs were transcribed at 37 °C overnight and then treated with DNaseI and 5 mM MgCl 2 (37 °C, 1 h) to quench the reaction and drive ribozyme cleavage. Before complexing with LbaCas13a, pre-crRNA was annealed in 1× annealing buffer (10 mM Na-HEPES, pH 7.4, 30 mM KCl, 1.5 mM MgCl 2 ) by heating at 75 °C for 5 min followed by rapid cooling on ice.
LbaCas13a-pre-crRNA complex formation. For crystallization, the LbaCas13a-crRNA or LbaCas13a (H328A) pre-crRNA complex was reconstituted in vitro by incubating purified LbaCas13a protein with pre-crRNA at a molar ratio of 1:1.3 at 37 °C for 1 h in complexing buffer (20 mM Na-HEPES, pH 7.0, 200 mM KCl, 1 mM TCEP). The complex was purified by size-exclusion chromatography (S200 10/300 Increase, GE Healthcare) in complexing buffer and concentrated using a 10 kDa Centricon (Thermo Fisher) before immediate use in crystallization experiments. The purity and integrity of protein and RNA were assessed using SDS-PAGE (Coomassie blue staining) and 15% (v/v) TBE-urea-PAGE (SYBR Gold straining), respectively (Supplementary Fig. 1b Structure determination by native SAD and model refinement. High-resolution data collected from LbaCas13a crystals at 11.1 keV were processed and scaled in XDS 31 before merging in AIMLESS 32, 33 . After being processed with XDS, each SAD data set was compared to every other data set after applying each of the 27 possible reindexing operations found by OTHERCELL 32 and then computing an isomorphous R factor with a 4-Å resolution cutoff using SCALEIT 32 . Pairs of data sets agreeing to more than 20% were grouped and merged using XSCALE 31 , producing a final cluster containing 20 wedges in the space group C2 (data statistics summarized in Table 1 ). The merged anomalous data were prepared for substructure search in SHELXC 34 and input into SHELXD set to search for 65 sites using a high-resolution cutoff of 3.5 Å. Nine solutions were found after 25,000 trials, and each solution was input separately into SHELXE. The correct substructure solution was found to contain a total of 115 sites, 32 of which were correct as determined using PHENIX.emma 35 . A readily interpretable map (CC 25%) was obtained after 30 cycles of density modification and model building in SHELXE. PHENIX.AutoBuild 36 was used to extend the initial α-helical model, complemented with manual model building in COOT 37 and RNA modeling with RCrane 38 . The atomic models were completed using iterative building and refinement in COOT and PHENIX.refine 39 against the high-resolution data using the 2mF o − DF c , mF o − DF c , anomalous Fourier difference and 2mF o − DF c composite omit 40 maps. The final models for LbaCas13a-crRNA (24-nt spacer), LbaCas13a-crRNA (20-nt spacer), and LbaCas13a(H328A)-pre-crRNA (24-nt spacer) were validated in MOLPROBITY 41 . All figures were generated in PyMOL (PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC http://www.pymol.org/).
Radiolabeled crRNA maturation assays. Pre-crRNA processing assays were performed as previously described 14 . Briefly, 100 nM LbaCas13a was incubated with <1 nM 5′-radiolabeled pre-crRNA substrates at 37 °C in processing buffer (20 mM HEPES-Na, pH 6.8, 50 mM KCl, 5 mM MgCl 2 , 10 µg/mL BSA, 100 µg/mL tRNA, 0.01% Igepal CA-630, and 5% glycerol). Reactions were quenched (100% formamide, 0.025% bromophenol blue, and 200 µg/mL heparin), denatured at 95 °C for 5 min, and resolved by 15% denaturing PAGE (0.5× TBE buffer). All bands were visualized by means of phosphorimaging (Typhoon, GE Healthcare) and quantified with ImageQuant (GE Healthcare). The percent cleavage was determined as the ratio of the intensity of the product band to the total intensity of both the product and uncleaved pre-crRNA bands and normalized for background within each measured substrate. For clarity, in some figure panels, the percentage of uncleaved substrates is presented (calculated as 100% cleaved).
Fluorescent ssRNA nuclease assays. Target cleavage assays were performed as previously described with minimal modification 14 . Briefly, 100 nM LbaCas13a was complexed with 50 nM pre-crRNAs at 37 °C in processing buffer for 30-60 min. Alternatively, cleavage buffer (20 mM HEPES-Na, pH 6.8, 50 mM KCl, 5 mM MgCl 2 ) was used for reactions instead of processing buffer as noted in the figure legends, resulting in less fluorescent signal generated. Generally, 150 nM RNase Alert reporter (IDT) and 10 nM of ssRNA activator were added to initiate the reaction. Reactions were incubated in a fluorescence plate reader (Tecan Infinite Pro F2000) for 60 min at 37 °C, with fluorescence measurements taken every 5 min (λ ex : 485 nm; λ em : 535 nm). Background-corrected values were calculated by subtracting signal in the negative control containing no activating RNA. For endpoint analyzes, the background corrected florescence value from the 60-min time point is presented (mean ± s.d., n = 3). Apparent rates were calculated according to a single exponential decay using Prism7 (GraphPad) fitted to the entire curve, and calculated rates were plotted with their associated s.d. (n = 3 independent measurements).
Filter-binding assays. Filter-binding assays were carried out as previously described 10 . Briefly, Cas13a and radiolabeled crRNA were incubated for 1 h at 37 °C in RNA-processing buffer (20 mM HEPES-Na, pH 6.8, 50 mM KCl, 5 mM MgCl 2 , 10 µg/mL BSA, 100 µg/mL yeast tRNA, 0.01% Igepal CA-630 and 5% glycerol). Tufryn, Protran and Hybond-N+ membranes were assembled onto a dot-blot apparatus in the order listed. The membranes were washed twice with 50 µL cleavage buffer (20 mM HEPES-Na, pH 6.8, 50 mM KCl, 5 mM MgCl 2 , and 5% glycerol) before the sample was applied to the membranes. Membranes were then washed with 50 µL cleavage buffer, dried, and visualized by means of phosphorimaging. Data were quantified with ImageQaunt TL Software (GE Healthcare) and fit to a binding isotherm using Prism7 (GraphPad). All experiments were carried out in triplicate.
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Data availability. The atomic coordinates and structure factors for the LbaCas13a-crRNA complexes have been deposited to the Protein Data Bank (PDB) under the accession codes PDB 5W1H for LbaCas13a-crRNA complex (24-nt spacer), PDB 5W1I for LbaCas13a-crRNA complex (20-nt spacer) and PDB 5WLH for LbaCas13a(H328A)-pre-crRNA complex (24-nt spacer). Source data for biochemical experiments that support the findings of this study are available from the corresponding author upon reasonable request.
